Streetbeat News

Price Targets

SEAT

Vivid Seats shares declined following price target reductions by Benchmark and Craig-Hallum.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:13 pm

TERN

Terns Pharmaceuticals shares are experiencing an increase in trading activity following JMP Securities' decision to raise its price target from $15 to $20.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:12 pm

MEOH

Methanex shares fell after Barclays downgraded the stock from Overweight to Equal-Weight and reduced its price target from $56 to $44.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:09 pm

PL

Goldman Sachs analyst Noah Poponak maintains a Buy rating on Planet Labs but lowers the price target from $3.5 to $3.1.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:05 pm

CMA

Stephens & Co. analyst Terry McEvoy has reiterated an Overweight rating on Comerica (NYSE:CMA) and maintained a price target of $58.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:04 pm

DK

EQR

JCI

ORCL

RLAY

Top Wall Street analysts have upgraded their ratings for several companies, including Oracle, Johnson Controls, Equity Residential, Delek US Holdings, and Relay Therapeutics. These upgrades reflect positive outlooks and increased price targets for these stocks.

Portfolio Pulse from Avi Kapoor

September 10, 2024 | 2:03 pm

NBTB

Stephens & Co. analyst Matt Breese has reiterated an Equal-Weight rating on NBT Bancorp (NASDAQ:NBTB) and maintained a price target of $49.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:01 pm

ZETA

DA Davidson analyst Clark Wright maintains a Buy rating on Zeta Global Holdings with a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:59 pm

DLTR

Goldman Sachs analyst Kate McShane maintains a Buy rating on Dollar Tree (NASDAQ:DLTR) but lowers the price target from $145 to $90.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:56 pm

PRGS

DA Davidson has reiterated its Buy rating for Progress Software (NASDAQ:PRGS) with a maintained price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:56 pm